Blood-derived biomarkers, such as neurofilament light (NfL) and glial fibrillary acidic protein (GFAP), could play a role in the diagnostic challenge currently faced in sporadic bvFTD. Here, NEFL is linked to behavioral variant of frontotemporal dementia.